| Sufian Jabbar Sorathia, MD | |
|
3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129-2349 | |
| (386) 788-1242 | |
| (386) 756-8802 |
| Full Name | Sufian Jabbar Sorathia |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 10 Years |
| Location | 3635 Clyde Morris Blvd Ste 100, Port Orange, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881018703 | NPI | - | NPPES |
| 108374600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME130655 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Borland Groover Clinic, Pa | 6507761301 | 113 |
News Archive
DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"In October 1987, Roy Vagelos, then the chief executive of pharmaceutical company Merck, launched the largest pharmaco-philanthropic venture ever," William Foege, an epidemiologist and former director of the CDC, writes in a Washington Post opinion piece highlighting the company's efforts to combat onchocerciasis in the developing world through the free distribution of its drug Mectizan.
› Verified 1 days ago
| Entity Name | Borland Groover Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881644912 PECOS PAC ID: 6507761301 Enrollment ID: O20031204000789 |
News Archive
DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"In October 1987, Roy Vagelos, then the chief executive of pharmaceutical company Merck, launched the largest pharmaco-philanthropic venture ever," William Foege, an epidemiologist and former director of the CDC, writes in a Washington Post opinion piece highlighting the company's efforts to combat onchocerciasis in the developing world through the free distribution of its drug Mectizan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sufian Jabbar Sorathia, MD 4800 Belfort Rd, Jacksonville, FL 32256-6004 Ph: (904) 398-7205 | Sufian Jabbar Sorathia, MD 3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129-2349 Ph: (386) 788-1242 |
News Archive
DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"In October 1987, Roy Vagelos, then the chief executive of pharmaceutical company Merck, launched the largest pharmaco-philanthropic venture ever," William Foege, an epidemiologist and former director of the CDC, writes in a Washington Post opinion piece highlighting the company's efforts to combat onchocerciasis in the developing world through the free distribution of its drug Mectizan.
› Verified 1 days ago
Vrushak Deshpande, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-756-8802 | |
Dr. Gregory J. Stella, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3635 S Clyde Morris Blvd, Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-788-4255 | |
Souheil Moussly, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3890 Turtle Creek Dr, Port Orange, FL 32129 Phone: 386-756-4400 Fax: 386-756-3031 | |
Robert Morris Harpold, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3953 S Nova Rd Ste B, Port Orange, FL 32127 Phone: 386-788-4911 Fax: 844-388-6186 | |
Dr. Ashraf S Elsakr, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 Dunlawton Ave, Ste A, Port Orange, FL 32127 Phone: 386-304-9672 Fax: 386-304-9673 | |
Nikenston Moise, PA Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3890 Turtle Creek Dr Ste C, Port Orange, FL 32127 Phone: 386-756-4400 | |
Raxitkumar Jinjuvadia, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-756-8802 |